Atazanavir

Excreted Unchanged %
7
Half-Life (Normalesrd) Hours
7/NA
Plasma Protein Binding %
86
Volume Of Distribution L/Kg
NA
Dose For Normal Renal Function
400 mg q24h
Adjustment For Renal Failure Gfr, Ml/Min >50 [Recommended Level]
No change [D]
Adjustment For Renal Failure Gfr, Ml/Min 10-50 [Recommended Level]
No data [D]
Adjustment For Renal Failure Gfr, Ml/Min <10 [Recommended Level]
No data [D]
Supplement For Dialysis [Recommendation Level]: Ihd
IHD: No data
Supplement For Dialysis [Recommendation Level]: Pd
PD: No data
Supplement For Dialysis [Recommendation Level]: Crrt
CRRT: No data, [B]
References
Izzedine H, Launay-Vacher V, Peytavin G, Valantin MA, Deray G. Atazanavir: a novel inhibitor of HIV-protease in haemodialysis [Letter]. Nephrol Dial Transplant. 2005; 20: 852-3. [PMID: 15772278]